AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

LifeMD, Inc. Director's Dealing 2017

Nov 22, 2017

33298_dirs_2017-11-22_681b8305-0331-40b8-a0f9-cec18b1f33e8.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: Galluppi Stefan (Director, Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	1150000	Indirect

Footnotes

F1: Mr. Galluppi beneficially owns these shares through his company American Nutra Tech, LLC